Oxytocin for Weight Loss: What the Evidence Shows
What human and animal studies show about Oxytocin for weight loss, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Human RCT
- Human studies
- 3
- with an outcome for weight loss, in our evidence file (PubMed search, 11 Oct 2026)
- Animal studies
- None found
- with an outcome for weight loss, in our evidence file (PubMed search, 11 Oct 2026)
- Studies we summarised
- 3
- with an outcome for weight loss
Evidence for weight loss
Each row is an outcome related to weight loss from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Lean mass (RESEARCH USE) | Whole-body lean mass rose 2.25 kg versus placebo (P < .01); fat mass only trended down. | Human RCTn = 21 | Journal of the American Medical Directors Association 2021, PMID 34029521 |
| Body mass index and appetite | No significant change in BMI, appetite, glycemia, HDL or triglycerides. | Human RCTn = 21 | Journal of the American Medical Directors Association 2021, PMID 34029521 |
| Food craving (RESEARCH USE) | Only a trend toward reduced food craving in the cognitive control condition. | Human RCTn = 31 | Human brain mapping 2016, PMID 27381253 |
| Obesity reduction (RESEARCH USE) | Pilot trial reported reduced obesity and reversal of prediabetic changes over 8 weeks; abstract gives no numbers. | Human RCT | PloS one 2013, PMID 23700406 |
Oxytocin and weight loss are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 11 Oct 2026). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What obesity means
In MedlinePlus's wording, an adult with a BMI of 30 or more is considered to have obesity.[4]
What the intranasal oxytocin weight trials measured
The registered primary outcome of the intranasal oxytocin obesity trial was the mean difference in weight loss between oxytocin and placebo 8 weeks after baseline.[5]
The published trial concluded that intranasal oxytocin four times daily for 8 weeks did not reduce body weight in adults with obesity.[6]
A secondary finding in that trial was lower calorie intake at the test meal on oxytocin than on placebo.[6]
In older adults with sarcopenic obesity, a pilot trial of intranasal oxytocin found no significant change in BMI or appetite scores.[1]
Craving and animal findings
In healthy women viewing food pictures, a single intranasal dose changed brain activity and the cognitive control of food craving, a laboratory measure rather than weight loss.[2]
Mouse studies reported that oxytocin and its analogs improved weight control, insulin sensitivity and insulin secretion (animal data).[3]
Other peptides people research for weight loss
All peptides for weight loss, comparedCommon questions
Does Oxytocin help with weight loss?
The strongest study we summarise for weight loss is human rct evidence, across 3 studies with an outcome for weight loss. A trial result is not an approval; see the legal status.
Is Oxytocin approved for weight loss?
Oxytocin is FDA approved (prescription only). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for weight loss?
There is no single answer. Our weight loss overview compares each candidate by evidence grade and legal status rather than by popularity.
Does oxytocin help weight loss?
In the one randomised trial built to test it, no: intranasal oxytocin did not reduce body weight over 8 weeks in adults with obesity.[6]
More on Oxytocin
Sources
- 1Intranasal Oxytocin Improves Lean Muscle Mass and Lowers LDL Cholesterol in Older Adults with Sarcopenic Obesity: A Pilot Randomized Controlled Trial.Journal of the American Medical Directors Association · 2021PMID 34029521Accessed 2 Oct 2026
- 2Oxytocin enhances cognitive control of food craving in women.Human brain mapping · 2016PMID 27381253Accessed 2 Oct 2026
- 3Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.PloS one · 2013PMID 23700406Accessed 2 Oct 2026
- 4Official web pageOfficial web page · web page
- 5A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Repeat Doses of Intranasal Oxytocin in Obese AdultsClinicalTrials.gov (U.S. National Library of Medicine) · 2017clinicaltrials.govAccessed 11 Oct 2026
- 6Intranasal Oxytocin for Obesity.NEJM evidence · 2024PMID 38815173Accessed 11 Oct 2026
Found an error? Report a correction.